KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Current Deferred Revenue (2023 - 2025)

Historic Current Deferred Revenue for Astrana Health (ASTH) over the last 3 years, with Q1 2025 value amounting to $686000.0.

  • Astrana Health's Current Deferred Revenue changed N/A to $686000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $686000.0, marking a year-over-year change of. This contributed to the annual value of $1.6 million for FY2024, which is 11586.02% up from last year.
  • Astrana Health's Current Deferred Revenue amounted to $686000.0 in Q1 2025.
  • Astrana Health's Current Deferred Revenue's 5-year high stood at $2.6 million during Q2 2024, with a 5-year trough of $686000.0 in Q1 2025.
  • In the last 3 years, Astrana Health's Current Deferred Revenue had a median value of $1.6 million in 2024 and averaged $1.6 million.
  • Over the last 5 years, Astrana Health's Current Deferred Revenue had its largest YoY gain of 11586.02% in 2024, and its largest YoY loss of 11586.02% in 2024.
  • Quarter analysis of 3 years shows Astrana Health's Current Deferred Revenue stood at $744000.0 in 2023, then soared by 115.86% to $1.6 million in 2024, then crashed by 57.29% to $686000.0 in 2025.
  • Its Current Deferred Revenue was $686000.0 in Q1 2025, compared to $1.6 million in Q4 2024 and $2.2 million in Q3 2024.